These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 5123908)

  • 1. Phenylalanine absorption and metabolism in Parkinsonian patients.
    Granerus AK; Jagenburg R; Rödjer S; Svanborg A
    Br Med J; 1971 Oct; 4(5782):262-4. PubMed ID: 5123908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral phenylalanine and tyrosine tolerance tests in Parkinsonian patients.
    Braham J; Sarova-Pinhas I; Crispin M; Golan R; Levin N; Szeinberg A
    Br Med J; 1969 May; 2(5656):552-5. PubMed ID: 5769891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variations in L-dopa absorption. Report of a parkinsonian patient with high plasma dopa concentration after therapeutical L-dopa dose.
    Granerus AK; Jagenburg R; Rödjer S; Svanborg A
    Acta Med Scand; 1974 Dec; 196(6):459-63. PubMed ID: 4456974
    [No Abstract]   [Full Text] [Related]  

  • 4. [Parkinson's syndrome. 11. Intestinal resorption].
    Jagenburg R
    Lakartidningen; 1970 Oct; 67(42):4842-4. PubMed ID: 5483445
    [No Abstract]   [Full Text] [Related]  

  • 5. Phenylalanine and tyrosine metabolism in Parkinson's disease treated with levodopa.
    Van Woert MH
    Clin Pharmacol Ther; 1971; 12(2):368-75. PubMed ID: 5577485
    [No Abstract]   [Full Text] [Related]  

  • 6. [Enteral absorption of phenylalanine in healthy subjects and phenylketonurics].
    Theile H; Beyreiss K
    Klin Wochenschr; 1967 Jul; 45(13):687-8. PubMed ID: 5589239
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral versus intravenous L-phenylalanine loading compared by simultaneous application of L-[2H5] and L-[15N]phenylalanine.
    Lehmann WD; Heinrich HC
    Clin Chim Acta; 1985 Apr; 147(3):261-6. PubMed ID: 3995775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of L-Phenylalanine absorption by L-DOPA in patients with parkinsonism.
    Granerus AK; Jagenburg R; Rödjer S; Svanborg A
    Proc Soc Exp Biol Med; 1971 Jul; 137(3):942-4. PubMed ID: 5560686
    [No Abstract]   [Full Text] [Related]  

  • 9. Kinetics of intravenous administered L-phenylalanine in patients with cirrohosis of the liver.
    Jagenburg R; Olsson R; Regårdh CG; Rodjer S
    Clin Chim Acta; 1977 Aug; 78(3):453-63. PubMed ID: 884870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous 24-h L-[1-13C]phenylalanine and L-[3,3-2H2]tyrosine oral-tracer studies at an intermediate phenylalanine intake to estimate requirements in adults.
    Basile-Filho A; el-Khoury AE; Beaumier L; Wang SY; Young VR
    Am J Clin Nutr; 1997 Feb; 65(2):473-88. PubMed ID: 9022533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intravenous phenylalanine loading test in normal subjects and the parents of phenylketonuretics].
    Badinand A; François R; Site J; Quincy C; Mamelle N; Masson E; Later R
    C R Seances Soc Biol Fil; 1968; 162(8):1525-8. PubMed ID: 4238174
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperaminoacidemia effects on intestinal transport of related amino acids.
    Wapnir RA; Hawkins RL; Lifshitz F
    Am J Physiol; 1972 Oct; 223(4):788-93. PubMed ID: 4263024
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of blood amino acids during a phenylalanine loading test].
    Dhondt JL; Farriaux JP
    Biomedicine; 1975 Apr; 23(4):149-54. PubMed ID: 1222234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-O-methyldopa and the response to levodopa in Parkinson's disease.
    Nutt JG; Woodward WR; Gancher ST; Merrick D
    Ann Neurol; 1987 Jun; 21(6):584-8. PubMed ID: 3606046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty-four-hour intravenous and oral tracer studies with L-[1-13C]phenylalanine and L-[3,3-2H2]tyrosine at a tyrosine-free, generous phenylalanine intake in adults.
    Sanchez M; El-Khoury AE; Castillo L; Chapman TE; Basile Filho A; Beaumier L; Young VR
    Am J Clin Nutr; 1996 Apr; 63(4):532-45. PubMed ID: 8599317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenylalanine and tyrosine requirements of immature beagle dogs.
    Milner JA; Garton RL; Burns RA
    J Nutr; 1984 Dec; 114(12):2212-6. PubMed ID: 6502264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal absorption of two dipeptides in Hartnup disease.
    Asatoor AM; Cheng B; Edwards KD; Lant AF; Matthews DM; Milne MD; Navab F; Richards AJ
    Gut; 1970 May; 11(5):380-7. PubMed ID: 5428040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anomalous phenylalanine loading responses in relation to cleft lip and cleft palate.
    Tocci PM; Beber B
    Pediatrics; 1973 Jul; 52(1):109-13. PubMed ID: 4737485
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence or age and sex on the kinetics of intravenously administered L-phenylalanine.
    Jagenburg R; Regårdh CG; Rödjer S
    Clin Chem; 1982 Jan; 28(1):204-6. PubMed ID: 7055913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic levodopa therapy enhances dopa absorption: contribution to wearing-off.
    Murata M; Mizusawa H; Yamanouchi H; Kanazawa I
    J Neural Transm (Vienna); 1996; 103(10):1177-85. PubMed ID: 9013404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.